Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.61
Delayed Data
As of 4:02pm ET
 +0.06 / +0.14%
Today’s Change
36.71
Today|||52-Week Range
45.58
+9.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues9.4B9.5B8.8B9.3B
 
 
 
 
 
Cost of Goods Sold2.8B3.4B2.2B2.4B
 
 
 
 
 
Depreciation And Amortization359.8M428.2M790.4M569.0M
 
 
 
 
 
 
Operating ExpensesGross Income6.2B5.6B5.8B6.3B
 
 
 
 
 
General Expenses4.0B5.4B4.3B4.3B
 
 
 
 
 
Other Operating Expenses135.3M--0.000.00
 
 
Research And Development1.1B1.6B1.2B1.3B
 
 
 
 
 
Total Operating Expenses7.3B9.2B7.3B7.4B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.1B291.0M1.5B1.9B
 
 
 
 
 
Extraordinary Credit4.6M--0.000.00
 
 
Extraordinary Charge-865.8M--0.000.00
 
 
Interest Expense On Debt256.8M298.6M256.4M259.7M
 
 
 
 
 
Equity In Earnings-3.1M-7.5M0.00-2.8M
 
 
 
 
Other Expenses313.7M-672.5M-522.7M-2.1B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.3B-619.7M793.2M-448.4M
 
 
 
 
 
Income Taxes-338.3M-18.1M-294.6M-246.9M
 
 
 
 
 
Minority Interest-167.6M-111.6M-99.2M-80.9M
 
 
 
 
 
Net Income827.3M-533.8M399.4M-617.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.4B2.4B2.4B2.4B
 
 
 
 
 
Shares To Calculate EPS Diluted2.4B2.4B2.4B2.4B
 
 
 
 
 
 
Earnings Per ShareEPS$0.34-$0.22$0.16-$0.26
 
 
 
 
 
EPS Diluted$0.34-$0.22$0.16-$0.26